Navigation Links
ULURU Inc. Reports Financial Results for Fourth Quarter and Year Ended December 31, 2010
Date:4/1/2011

$796,000 in revenues from the fourth quarter of 2009 compared to the fourth quarter of 2010 was primarily due to increased licensing fees due to the recognition of $751,000 in unamortized licensing fees from the termination of the licensing agreement with Meldex International.

For the year ended December 31, 2010, revenues were $1,557,000, compared to $668,000 for the same period of 2009.  The increase of approximately $889,000 was due primarily to the following factors: an increase of $903,000 in OraDisc™ licensing fees and an increase of $138,000 in Aphthasol® product sales as we did not sell any Aphthasol® finished product to our domestic distributor during 2009.  These increases were partially offset by decreases in Zindaclin® royalty and licensing fees of $87,000 due to our divestiture of this product in June 2010.

Research and Development

Research and development expenses for the fourth quarter of 2010 were $309,000, including $32,000 in share-based compensation, compared to $244,000, including $34,000 in share-based compensation, for the fourth quarter of 2009.  The increase of approximately $65,000 in research and development expenses was primarily due to higher costs of $50,000 associated with the development efforts for our Altrazeal® and OraDisc™ technologies.  

For the year ended December 2010, research and development expenses were $1.26 million, including $136,000 in share-based compensation, compared to $2.25 million, including $320,000 in share-based compensation, for the same period in 2009. The decrease of approximately $992,000 in research and development expenses was due primarily to decreases in direct research costs of $73,000, scientific personnel costs of $561,000, clinical testing expenses for our wound care technologies of $163,000, and regulatory consulting of $195,000.

Selling, general and administrative

Selling, general and admini
'/>"/>

SOURCE ULURU Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. ULURU Inc. Announces Conference Call to Discuss Financial Results for the Fourth Quarter and Year Ended December 31, 2010 and to Provide a Business Update
2. ULURU Inc. Announces the Filing of a 510(k) Application to Expand Altrazeal®s Label Claim
3. ULURU Inc. Receives Letter of Non-Compliance From NYSE Amex
4. ULURU Inc. Announces Agreement With Exciton to Develop Antimicrobial Dressing
5. ULURU Inc. to Raise $500,000 in Registered Direct Offering
6. ULURU Inc. Reports Third Quarter 2010 Financial Results
7. ULURU Inc. Provides Altrazeal® Clinical Update
8. ULURU Inc. Announces Conference Call
9. ULURU Inc. Reports Second Quarter 2010 Financial Results
10. ULURU Inc. Invited to Present Altrazeal(TM) Research at 10th Annual Wound Healing Science and Industry Conference
11. ULURU Inc. Obtains Status of Approved Supplier With McKesson.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2014)... SANTA CLARA, Calif. , Sept. 2, 2014 /PRNewswire/ ... , is now offering a special promotion for Invisalign. ... instead of brackets and wires. It is often the ... who prefer the convenience and aesthetics of it. For ... $3,900, which is a significant savings from the usual ...
(Date:9/2/2014)... September 2, 2014 , ... 2014 provide insight into treatment and outcomes of ... practice --   Data from nearly ... in the FIELD-Atrial Fibrillation (GARFIELD-AF), an innovative, independent ... strategies for atrial fibrillation (AF) patients remain sub-optimal ...
(Date:9/2/2014)... , Sept. 2, 2014 /PRNewswire-iReach/ -- Ortho Development® ... Alpine™ Hip Stem, the latest addition to its ... Stem is intended for use in total hip ... http://photos.prnewswire.com/prnh/20140830/141676 Alpine was ... stem philosophy. ODEV,s engineers worked closely with a ...
Breaking Medicine Technology:Santa Clara Cosmetic Dentist, Dr. Alan Frame, is Now Offering a Special on Invisalign 2Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 2Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 3Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 4Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 5Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 6Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 7Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 8Data From Global Atrial Fibrillation Registry Show Antithrombotic Agents Not Optimally Used to Prevent Stroke 9Ortho Development Receives FDA Clearance for Alpine Hip Stem 2
(Date:9/2/2014)... Two Kansas State University biochemists have discovered a ... for Staphylococcus aureus , a pathogenic bacterium that ... year. , Brian Geisbrecht, professor of biochemistry and molecular ... S. aureus , which is the cause of ... scientific journal Proceedings of the National Academy of ...
(Date:9/2/2014)... -- Many people believe that marijuana is not addictive, ... more people are able to obtain and consume cannabis ... people are less likely to perceive it as addictive ... Massachusetts General Hospital,s Center for Addiction Medicine, said in ... cannabis use can have significant consequences, and we know ...
(Date:9/2/2014)... Mass. (PRWEB) September 02, 2014 Healthcare ... latest and most complete oncology guidelines available at the ... Health and the National Comprehensive Cancer Network® ... with other evidence and guidelines in the content available ... , NCCN, a not-for-profit alliance of 25 of ...
(Date:9/2/2014)... that the key to more youthful immune function might ... published in the Journal of Leukocyte Biology ... of old mice had different responses to Mycobacterium ... changes were reversed by ibuprofen. , "Inflammation in old ... Joanne Turner, Ph.D., a researcher involved in the work ...
(Date:9/2/2014)... 02, 2014 Nanomedicine is essentially ... diagnosing, treating and/or prevention of diseases and infections. ... cardiovascular, neurological, and oncology diseases. , Nanomedicine ... to various nanoparticles, their medical usages, and their ... considerable scope for research in this domain, and ...
Breaking Medicine News(10 mins):Health News:Biochemists find new treatment options for staph infections, inflammatory diseases 2Health News:'Pot Addiction' May Be Real, Study Suggests 2Health News:DynaMed™ to Utilize Information from the National Comprehensive Cancer Network® 2Health News:DynaMed™ to Utilize Information from the National Comprehensive Cancer Network® 3Health News:DynaMed™ to Utilize Information from the National Comprehensive Cancer Network® 4Health News:Nanomedicine Market: An Overview of Growth Factors and Future Prospects by Transparency Market Research 2Health News:Nanomedicine Market: An Overview of Growth Factors and Future Prospects by Transparency Market Research 3
... we interviewed a doctor - Dr.Makani Hemadri, who has seen ... facing the doctor community at large objectively. Many doctors ... Apparently almost 25,000 doctors of Indian orgin serve the National ... countries as distant and remote as Fiji, Belize and Zambia ...
... have not lost faith, but we have transferred it from ... ,Healthcare in India is presently the cynosure of ... medical brains, is also recording excellence in healthcare services. ... India is on the road to being an important healthcare ...
... painful rashes. Prescription medications including steroid creams that ... ,When over five million Americans suffer from that ... frenzied response, especially when backed by some kind of ... even though experts are skeptical. ,"We can ...
... by University of Leeds researchers suggests that proteins that ... against Alzheimer's. ,In laboratory tests, the ... the brain prevented the accumulation of beta amyloid, the ... leader Professor Nigel Hooper says that the findings, published ...
... anthropologists have embarked on a project to save Tibetan folk ... Gerald Roche, the volunteer-run Tibetan Endangered Music Project (TEMP) aims ... return them back to the community. ,"The goal ... to our communities. We want to record as many songs ...
... a growing segment of the population but vote less ... favor Democrats over Republicans, said a study published Friday. ... older now account for 45.2 percent of the US ... Vote said in its study titled "Unmarried America 2007: ...
Cached Medicine News:Health News:Interview With a Surgeon Hidden Hero of the NHS 2Health News:Interview With a Surgeon Hidden Hero of the NHS 3Health News:Interview With a Surgeon Hidden Hero of the NHS 4Health News:Interview With a Surgeon Hidden Hero of the NHS 5Health News:Interview With a Surgeon Hidden Hero of the NHS 6Health News:Interview With a Surgeon Hidden Hero of the NHS 7Health News:Interview With a Surgeon Hidden Hero of the NHS 8Health News:Lets Care For Our Physicians A Salute to Them on Doctors Day! 2Health News:Lets Care For Our Physicians A Salute to Them on Doctors Day! 3Health News:Experts Critical of a New OTC Product to Treat Psoriasis 2Health News:Experts Critical of a New OTC Product to Treat Psoriasis 3Health News:Proteins Behind Mad Cow Disease may Protect Against Alzheimer's 2Health News:Digital Music Project Aims to Save Tibetan Folk Songs from Extinction 2Health News:Single Americans Vote Less, but Lean Towards Democrats: Study 2
A wide selection of bipolar forceps and hemostatic erasers to facilitate most ophthalmic surgical procedures....
Mendez Multi-Purpose LASIK Forceps. To enter, dissect, elevate and smooth the flap. Combined features of Spatula, Dissector and Forceps, Titanium...
To enter, dissect, elevate and smooth the flap. Combined features of Spatula, Dissector and Forceps. - Also available in Titanium...
Khosla Precision and Quality in Medical and Surgical Products....
Medicine Products: